Malignant peripheral nerve sheath tumors: a report from Children’s Oncology Group study ARST0332
The treatment strategy in ARST0332 achieved excellent outcomes for low-risk MPNST. Patients with high risk (metastatic) MPNST have poor outcomes and novel treatments are needed. (NCT00346164).
Authors
- Susan M. Hiniker (ORCID: https://orcid.org/0000-0003-4723-2151)
- Aaron R. Weiss (ORCID: https://orcid.org/0000-0001-8352-3963)
- Amira Qumseya
- Donald A. Barkauskas (ORCID: https://orcid.org/0000-0002-2339-719X)
- Roshni Dasgupta (ORCID: https://orcid.org/0000-0003-4839-4937)
- Serena Y. Tan (ORCID: https://orcid.org/0000-0001-5409-0695)
- Khang Chau (ORCID: https://orcid.org/0000-0002-9112-2470)
- Jacquelyn Crane (ORCID: https://orcid.org/0000-0002-8227-5694)
- Rajkumar Venkatramani (ORCID: https://orcid.org/0000-0002-4785-106X)
- Sheri L. Spunt (ORCID: https://orcid.org/0000-0002-1669-2676)
- Theodore Willis Laetsch (ORCID: https://orcid.org/0000-0002-8497-3138)
- Wei Xue
Institutions
- University of Southern California (US)
- Cincinnati Children's Hospital Medical Center (US)
- Children's Medical Center (US)
- Children's Hospital of Philadelphia (US)
- AbbVie (United States) (US)
- MaineHealth (US)
- Stanford Medicine (US)
- Texas Children's Hospital (US)
- Children's Cancer Center (US)
- University of Cincinnati (US)
- Florida College (US)
- Stanford University (US)
Publication Details
- Journal
- JNCI Journal of the National Cancer Institute
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1093/jnci/djaf359
- Primary Topic
- Neurofibromatosis and Schwannoma Cases
- Type
- article
- Field-Weighted Citation Impact
- 0.00